Marina Mendiburu-Eliçabe, Natalia García-Sancha, Roberto Corchado-Cobos, Angélica Martínez-López, Hang Chang, Jian Hua Mao, Adrián Blanco-Gómez, Ana García-Casas, Andrés Castellanos-Martín, Nélida Salvador, Alejandro Jiménez-Navas, Manuel Jesús Pérez-Baena, Manuel Adolfo Sánchez-Martín, María Del Mar Abad-Hernández, Sofía Del Carmen, Juncal Claros-Ampuero, Juan Jesús Cruz-Hernández, César Augusto Rodríguez-Sánchez, María Begoña García-Cenador, Francisco Javier García-Criado, Rodrigo Santamaría Vicente, Sonia Castillo-Lluva, Jesús Pérez-Losada
Despite their generally favorable prognosis, luminal A tumors paradoxically pose the highest ten-year recurrence risk among breast cancers. From those that relapse, a quarter of them do it within five years after diagnosis. Identifying such patients is crucial, as long-term relapsers could benefit from extended hormone therapy, whereas early relapsers may require aggressive treatment. In this study, we demonstrate that NCAPH plays a role in the pathogenesis of luminal A breast cancer, contributing to its adverse progression in vitro and in vivo ...
October 16, 2023: Research Square